Handok (002390) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Handok (002390) has a cash flow conversion efficiency ratio of -0.058x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-16.13 Billion ≈ $-10.93 Million USD) by net assets (₩278.32 Billion ≈ $188.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Handok liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Handok - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Handok's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Handok Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Handok ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NPC Co. Ltd
KO:004250
|
0.040x |
|
Hyundai E P
KO:089470
|
-0.028x |
|
Groupe LDLC SA
PA:ALLDL
|
-0.164x |
|
Dongnam Chem
KO:023450
|
-0.002x |
|
Big Ridge Gold Corp
V:BRAU
|
-0.080x |
|
RoboRobo Co. Ltd
KQ:215100
|
0.006x |
|
CENIT Aktiengesellschaft
XETRA:CSH
|
0.303x |
|
Xin Chio Global Co Ltd
TWO:3171
|
0.084x |
Annual Cash Flow Conversion Efficiency for Handok (2011–2025)
The table below shows the annual cash flow conversion efficiency of Handok from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see 002390 company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩278.32 Billion ≈ $188.61 Million |
₩3.98 Billion ≈ $2.70 Million |
0.014x | +248.38% |
| 2024-12-31 | ₩289.06 Billion ≈ $195.89 Million |
₩-2.79 Billion ≈ $-1.89 Million |
-0.010x | -109.13% |
| 2023-12-31 | ₩340.63 Billion ≈ $230.84 Million |
₩35.98 Billion ≈ $24.38 Million |
0.106x | +32.15% |
| 2022-12-31 | ₩381.86 Billion ≈ $258.78 Million |
₩30.52 Billion ≈ $20.68 Million |
0.080x | -17.56% |
| 2021-12-31 | ₩384.00 Billion ≈ $260.23 Million |
₩37.23 Billion ≈ $25.23 Million |
0.097x | +52.09% |
| 2020-12-31 | ₩381.85 Billion ≈ $258.77 Million |
₩24.34 Billion ≈ $16.50 Million |
0.064x | +149.23% |
| 2019-12-31 | ₩343.99 Billion ≈ $233.12 Million |
₩8.80 Billion ≈ $5.96 Million |
0.026x | -72.79% |
| 2018-12-31 | ₩313.38 Billion ≈ $212.37 Million |
₩29.46 Billion ≈ $19.96 Million |
0.094x | +302.39% |
| 2017-12-31 | ₩290.71 Billion ≈ $197.01 Million |
₩6.79 Billion ≈ $4.60 Million |
0.023x | +179.47% |
| 2016-12-31 | ₩289.25 Billion ≈ $196.02 Million |
₩-8.50 Billion ≈ $-5.76 Million |
-0.029x | -160.97% |
| 2015-12-31 | ₩303.71 Billion ≈ $205.82 Million |
₩14.64 Billion ≈ $9.92 Million |
0.048x | -59.42% |
| 2014-12-31 | ₩307.77 Billion ≈ $208.57 Million |
₩36.56 Billion ≈ $24.78 Million |
0.119x | +276.75% |
| 2013-12-31 | ₩294.28 Billion ≈ $199.43 Million |
₩9.28 Billion ≈ $6.29 Million |
0.032x | -26.21% |
| 2012-12-31 | ₩287.25 Billion ≈ $194.67 Million |
₩12.28 Billion ≈ $8.32 Million |
0.043x | -75.26% |
| 2011-12-31 | ₩278.34 Billion ≈ $188.62 Million |
₩48.08 Billion ≈ $32.59 Million |
0.173x | -- |
About Handok
HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food sup… Read more